Related Experiment Videos
Prognostic histopathological factors in malignant melanoma
Pathology
|April 1, 1985
Summary
Prognostic factors for cutaneous malignant melanoma lose predictive power as the disease advances. For advanced melanoma, survival depends on metastasis extent, not primary tumor features.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Cutaneous malignant melanoma (CMM) prognosis is influenced by various factors.
- Understanding how prognostic factors change with disease stage is crucial for accurate survival prediction.
Purpose of the Study:
- To analyze the predictive value of primary melanoma histological features across different stages of disease.
- To identify key prognostic indicators for localized, regional, and distant metastatic melanoma.
Main Methods:
- Retrospective analysis of 4000 patients with CMM.
- Evaluation of prognostic factors including tumor thickness, ulceration, invasion level, and regression.
- Comparison of predictive power of primary lesion features in localized vs. metastatic disease.
Main Results:
- In localized melanoma, tumor thickness, ulceration, invasion level, and regression were independent predictors of survival.
- In regional lymph node metastasis, only ulceration remained a significant predictor.
- In distant metastatic disease, primary lesion features lost predictive value; prognosis was determined by the extent of metastasis (number of positive lymph nodes or number/location of metastatic sites).
Conclusions:
- The predictive significance of primary melanoma histological features diminishes with disease progression.
- For advanced melanoma, metastatic burden is the primary determinant of patient survival.
- Staging and assessment of metastatic spread are critical for prognostication in later-stage melanoma.